Literature DB >> 7193425

Thrombocytopenia with decreased megakaryocytes. Evaluation and prognosis.

D B Stoll, S Blum, D Pasquale, S Murphy.   

Abstract

The presenting clinical pictures and courses of seven patients with thrombocytopenia, decreased megakaryocytes in the marrow, and minimal changes in other hematopoietic cell lines are described. Little information exists in the literature on such patients. Initial bone marrow aspiration and biopsy in all patients showed decreased megakaryocytes with an otherwise normal marrow. Erythrocyte mean corpuscular volume was elevated in five of seven patients. Bone marrow karyotypes of six of the seven patients were normal. Chromium-51 platelet survival studies with platelet sizing, done in five of the seven patients, showed normal results. In two patients the course progressed to aplastic anemia. One of these died 9 months after presentation, and one responded dramatically to lithium. One patient developed preleukemia and died. The other four patients have remained thrombocytopenic but clinically stable. No useful therapy was identified. The differential diagnosis of such patients should include idiopathic thrombocytopenic purpura with misinterpretation of morphologic findings, hereditary and acquired aplastic anemia, preleukemia, and systemic lupus erythematosus.

Entities:  

Mesh:

Year:  1981        PMID: 7193425     DOI: 10.7326/0003-4819-94-2-170

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  7 in total

Review 1.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.

Authors:  W Kayser; H H Euler; N Schmitz; W Gassmann; H Löffler; F Asbeck
Journal:  Blut       Date:  1985-12

3.  Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma.

Authors:  R Hoffman; H H Yang; E Bruno; J E Straneva
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

4.  Human megakaryocytic progenitor cells.

Authors:  L Kanz; G W Löhr; A A Fauser
Journal:  Klin Wochenschr       Date:  1987-04-01

5.  Danazol: an effective option in acquired amegakaryocytic thrombocytopaenic purpura.

Authors:  E Mulroy; S Gleeson; S Chiruka
Journal:  Case Rep Hematol       Date:  2015-04-05

6.  Myelodysplastic Syndrome Presenting as Amegakaryocytic Thrombocytopenia in a Collodion Baby.

Authors:  Mohammed Al Pakra; Abdullah Al Jabri; Ehab Hanafy
Journal:  J Investig Med High Impact Case Rep       Date:  2015-09-10

7.  Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.

Authors:  Takanori Ichikawa; Yasuhiro Shimojima; Toshiaki Otuki; Ken-Ichi Ueno; Dai Kishida; Yoshiki Sekijima
Journal:  Intern Med       Date:  2019-08-06       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.